February 15, 2012

Orbimed Advisors' 12/31/11 13F

Corporate advisory board member David Darst is a member of Orbimed's private equity team (not its public equity team). Orbimed's 12/31/11 13F filing shows no Provectus holdings. I put Orbimed in the group of investors that know the company very well but are waiting for a PR stating Provectus has received the SPA before they will buy shares.

No comments:

Post a Comment